Target intelligence / Profile preview

MIR2052 host gene (MIR2052HG)

Target: MIR2052HG
Molecular classification: Long noncoding RNA (lncRNA), Non-protein-coding gene

Overview

MIR2052 host gene (MIR2052HG) encodes a long noncoding RNA (lncRNA) implicated in the regulation of gene expression at the post-transcriptional and transcriptional levels. It is involved in cancer progression, particularly hepatoblastoma, by sponging specific microRNAs (miR-514a-5p and miR-205-5p), which in turn regulate key pathways such as MAPK and PI3K/AKT. MIR2052HG is associated with increased cell proliferation, migration, and invasion in cancer cells. It has been proposed as a novel biomarker and potential therapeutic target in cancer, but as of now, it is not classically targeted by existing therapeutics.

Other names: MIR2052HGLncRNA MIR2052HGMIR2052 host gene

Mechanism of action

Not applicable (no drugs target this lncRNA directly). MIR2052HG acts biologically by sponging microRNAs such as miR-514a-5p and miR-205-5p and regulating downstream oncogenic pathways such as MAPK and PI3K/AKT signaling.

Biological functions

Regulation of cell proliferationRegulation of cell differentiationModulation of gene transcriptionCompeting endogenous RNA (ceRNA) activity, i.e., "miRNA sponge"

Disease associations

Cancer (e.g., hepatoblastoma, possibly other cancers)Pregnancy loss(Other putative roles in cancer biology are being investigated.)

Safety considerations

No therapeutic interventions currently target MIR2052HG, so drug-related safety concerns are not defined. General challenges for lncRNA targeting (e.g., specificity, delivery, and potential off-target effects) would be relevant for future drug development.

Biomarkers

MIR2052HG expression has been proposed as a molecular biomarker for hepatoblastoma progression, and potentially as a marker in other cancer contexts

Beyond the preview

Go deeper on MIR2052 host gene (MIR2052HG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MIR2052 host gene (MIR2052HG).

Explore the full profile